4//SEC Filing
Bhatia Sangeeta N. 4
Accession 0000875320-24-000211
CIK 0000875320other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:12 PM ET
Size
8.1 KB
Accession
0000875320-24-000211
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-30$152.74/sh+646$98,670→ 5,081 total - Sale
Common Stock
2024-08-30$500.00/sh−646$323,000→ 4,435 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-30−646→ 0 totalExercise: $152.74Exp: 2028-05-31→ Common Stock (646 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001643921
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:12 PM ET
- Size
- 8.1 KB